Related references
Note: Only part of the references are listed.IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
Ting Zhou et al.
NATURE (2020)
Inherited IL-18BP deficiency in human fulminant viral hepatitis
Serkan Belkaya et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
TOX is a critical regulator of tumour-specific T cell differentiation
Andrew C. Scott et al.
NATURE (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
Eric S. Weiss et al.
BLOOD (2018)
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
Norio Chihara et al.
NATURE (2018)
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M. Levin et al.
NATURE (2012)
Share Paper
